Microlenyn 30 ED Adverse Reactions

Serious: Arterial thromboembolism, cerebral hemorrhage, cerebral thrombosis, coronary thrombosis, focal nodular hyperplasia of the liver, gall bladder disease, hepatic adenomas or benign liver tumors, hypertension, mesenteric thrombosis, myocardial infarction, pulmonary embolism, ruptured cyst, thrombophlebitis and venous thrombosis with or without embolism, uterine leiomyoma.
CNS: Dizziness, headache, mental depression, migraine.
Dermatologic: Melasma, rash.
Endocrine: Breast pain, tenderness, enlargement, secretion diminution in lactation when given immediately postpartum.
GI: Abdominal cramp, bloating, cholestatic jaundice, nausea and vomiting.
GU: Amenorrhea during and after treatment, breakthrough bleeding, spotting, change in menstrual flow, change in cervical erosion and secretions, invasive cervical cancer, temporary infertility after discontinuation, vaginal candidiasis.
Ophthalmic: Changes in corneal curvature, contact lens intolerance, neuro-ocular lesions.
Miscellaneous: Edema, reduced carbohydrate tolerance, weight change, prevalence of cervical Chlamydia trachomatis may be increased, hirsutism.